Etaracizumab
Etaracizumab | |
---|---|
Term | Etaracizumab |
Short definition | Etaracizumab (eh-TAR-uh-SIH-zoo-mab) A substance being studied to treat some types of cancer and other diseases. Etaracizumab attaches to a protein on the surface of blood vessels and can prevent the growth of new blood vessels that tumors need to grow. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Etaracizumab - (pronounced) (eh-TAR-uh-SIH-zoo-mab) A substance being studied to treat some types of cancer and other diseases. Etaracizumab attaches to a protein on the surface of blood vessels and can prevent the growth of new blood vessels that tumors need to grow. It can also prevent the spread of cancer. It's a type of anti-angiogenesis drug, a type of anti-metastatic drug, and a type of monoclonal antibody. Also called Abegrin, humanized monoclonal antibody MEDI-522 and MEDI-522
External links
- Medical encyclopedia article on Etaracizumab
- Wikipedia's article - Etaracizumab
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski